Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Axonics Modulation Technologies Inc | 9 | 0 | 0 | 0 | €61.00 | €66.53 | 9.064% |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €67.28 | €100.00 | 48.633% |
| Becton, Dickinson & Co. | 9 | 0 | 1 | 0 | €218.80 | €268.91 | 22.901% |
| Biogen Inc. | 46 | 1 | 6 | 1 | €205.70 | €294.01 | 42.932% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 3 | 0 | €76.16 | €102.62 | 34.741% |
| Bio-Rad Labs Inc. A | 7 | 0 | 1 | 0 | €261.90 | €445.58 | 70.135% |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €75.50 | €75.94 | 0.577% |
| Blueprint Medicines Corp | 2 | 0 | 2 | 0 | €99.02 | - | - |
| Boston Scientific | 46 | 0 | 10 | 0 | €68.50 | €73.05 | 6.638% |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.35 | - | - |
| Brookdale Sr Lvg | 2 | 0 | 0 | 0 | €6.45 | €8.27 | 28.260% |
| Bruker Corp. | 7 | 1 | 0 | 0 | €70.30 | €85.68 | 21.884% |
| Cara Therapeutics Inc. | 8 | 1 | 0 | 0 | €0.67 | €4.63 | 595.090% |
| Catalent Inc. | 2 | 0 | 0 | 0 | €51.82 | €55.00 | 6.137% |
| Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | €14.80 | €24.13 | 63.117% |
| Celldex Therapeutics | 10 | 1 | 1 | 0 | €38.40 | €51.25 | 33.453% |
| Cellectar BioSciences Inc. | 7 | 8 | 0 | 0 | €2.86 | €10.55 | 268.734% |
| Centene Corp. | 15 | 0 | 3 | 0 | €72.22 | €82.57 | 14.332% |
| Cerus Corp. | 4 | 0 | 2 | 0 | €1.61 | €3.26 | 102.129% |
| Charles River Labs Intl | 10 | 0 | 1 | 0 | €212.20 | €248.57 | 17.139% |
| Chemed Corp. | 5 | 0 | 1 | 0 | €535.00 | €588.14 | 9.933% |
| Chimerix Inc. | 4 | 1 | 0 | 0 | €0.90 | €5.51 | 515.469% |
| Chromadex Corp | 11 | 2 | 1 | 0 | €3.42 | €5.58 | 63.035% |
| Cigna Corp. | 17 | 0 | 2 | 0 | €323.35 | €342.35 | 5.876% |
| Cocrystal Pharma Inc. | 6 | 0 | 0 | 0 | €1.46 | €10.08 | 590.274% |